The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Wellington Management reported reduced short position from 0.65% to 0.39% on last Friday.I reckon under 2M shares. Logically, they and sister company Wellington Management Company LLP will be reducing the shorts further.
NewKOTB, I was also thinking maybe the shorters wanted to bring the price down to buy them back. There are about 1.5 shares traded, which make up only 0.2% of total shares, far less than even their short positions. It is so god damn easy to manipulate the share price. This stock is a lucrative business.
It is a chicken-and-egg problem, " startups do not aspire to achieve their maximum potential" because of lack of support from VC, government and stock market. It is better off selling the company than listing in London only to have stock price trashed by shorters.